Patterson Companies reported a 5.0% increase in net sales to $1.72 billion for the fourth quarter of fiscal 2023, with internal sales increasing by 5.7%. GAAP earnings were $0.77 per diluted share, and adjusted earnings were $0.84 per diluted share, an 18% increase year-over-year. The company also issued fiscal 2024 GAAP earnings guidance of $2.14 to $2.24 per diluted share and adjusted earnings guidance of $2.45 to $2.55 per diluted share.
Fourth quarter reported net sales increased 5.0 percent year-over-year to $1.7 billion, and internal sales increased 5.7 percent.
Adjusted operating margin expansion occurred during the fourth quarter and fiscal 2023 for business overall and across both Dental and Animal Health segments.
$156.8 million was returned to shareholders in fiscal 2023 through dividends and share repurchases.
Fourth quarter GAAP earnings were $0.77 per diluted share and adjusted earnings of $0.84 per diluted share, an increase of 18 percent over prior year.
Patterson Companies issued its fiscal 2024 earnings guidance, expecting GAAP earnings to be in the range of $2.14 to $2.24 per diluted share and non-GAAP adjusted earnings to be in the range of $2.45 to $2.55 per diluted share.
Visualization of income flow from segment revenue to net income